Search Results
Search results for "Edward Stites"
Results found for "Edward Stites"
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
He obtained both his MS and Ph.D. in Neuroendocrine Physiology at Florida State University before completing
- Antonella Di Pizio: Computational Pharmacology of Taste and Olfactory Receptors | Dr. GPCR Ecosystem
Di Pizio's workflow is deliberately iterative: build the model, predict binding-site residues, send them
- Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem
determines whether a signal flows through disheveled or through a G protein depending on its conformational state
- Lin and Ball: GPCR Antibody Characterization and the Recombinant Shift | Dr. GPCR Ecosystem
Is More Honest Than "Validated" - and the Difference Matters The word "validated" implies a finished state
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
addictions, one of the most consequential changes is the shift from goal-directed to habitual behavior: a state
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
including early homology modeling, coarse-grained molecular dynamics, and genetic code expansion for site-specific
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
influence on receptor pharmacology appears to be primarily allosteric - subtly reshaping the GPCR binding site
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
found agonists: compounds that made the G-protein bind better, some of which trapped the receptor in a state
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
equilibrioception GPCR Activation and Signaling Extensive location bias of the GPCR-dependent translatome via site-selective
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
🧬 Receptor Flexibility : Ligands stabilize different receptor states, creating unique signaling pathways therapeutic outcomes. 📌 Receptors are Dynamic Players 🔹 Different ligands trigger unique receptor states









